165 related articles for article (PubMed ID: 19194828)
41. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
[TBL] [Abstract][Full Text] [Related]
42. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
[TBL] [Abstract][Full Text] [Related]
43. [Methylation status of RASSF1A and DAPK promoter in retinoblastoma].
Liu R; Gao L; Lu GX; Tang LS; Zhu XH; Wang J
Zhonghua Yan Ke Za Zhi; 2009 Jul; 45(7):631-5. PubMed ID: 19957692
[TBL] [Abstract][Full Text] [Related]
44. Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors.
Rykova EY; Laktionov PP; Skvortsova TE; Starikov AV; Kuznetsova NP; Vlassov VV
Ann N Y Acad Sci; 2004 Jun; 1022():217-20. PubMed ID: 15251963
[TBL] [Abstract][Full Text] [Related]
45. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
[TBL] [Abstract][Full Text] [Related]
46. Modulation of gene methylation by genistein or lycopene in breast cancer cells.
King-Batoon A; Leszczynska JM; Klein CB
Environ Mol Mutagen; 2008 Jan; 49(1):36-45. PubMed ID: 18181168
[TBL] [Abstract][Full Text] [Related]
47. Effects of ILTG on DAPK1 promoter methylation in colon and leukemia cancer cell lines.
Zorko BA; Pérez LB; De Blanco EJ
Anticancer Res; 2010 Oct; 30(10):3945-50. PubMed ID: 21036707
[TBL] [Abstract][Full Text] [Related]
48. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
49. Methylation-specific loop-mediated isothermal amplification for detecting hypermethylated DNA in simplex and multiplex formats.
Zerilli F; Bonanno C; Shehi E; Amicarelli G; Adlerstein D; Makrigiorgos GM
Clin Chem; 2010 Aug; 56(8):1287-96. PubMed ID: 20551384
[TBL] [Abstract][Full Text] [Related]
50. Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors.
Christoph F; Kempkensteffen C; Weikert S; Krause H; Schostak M; Miller K; Schrader M
Cancer Lett; 2007 Mar; 247(1):137-42. PubMed ID: 16697107
[TBL] [Abstract][Full Text] [Related]
51. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
52. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy.
Browne EP; Punska EC; Lenington S; Otis CN; Anderton DL; Arcaro KF
Epigenetics; 2011 Dec; 6(12):1425-35. PubMed ID: 22139572
[TBL] [Abstract][Full Text] [Related]
53. [Reactivation of hypermethylated GSTP1 promoter activity in MCF-7 cells by treatment with a component of natural drug].
Zhang JZ; Wang JH; Qin Y; Fu Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):761-5. PubMed ID: 17953352
[TBL] [Abstract][Full Text] [Related]
54. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.
Euhus DM; Bu D; Ashfaq R; Xie XJ; Bian A; Leitch AM; Lewis CM
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1812-21. PubMed ID: 17855699
[TBL] [Abstract][Full Text] [Related]
55. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer.
Viet CT; Jordan RC; Schmidt BL
J Calif Dent Assoc; 2007 Dec; 35(12):844-9. PubMed ID: 18240747
[TBL] [Abstract][Full Text] [Related]
56. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.
López F; Sampedro T; Llorente JL; Domínguez F; Hermsen M; Suárez C; Alvarez-Marcos C
Oral Oncol; 2014 Apr; 50(4):291-7. PubMed ID: 24444674
[TBL] [Abstract][Full Text] [Related]
57. DNA methylation in benign breast epithelium in relation to age and breast cancer risk.
Euhus DM; Bu D; Milchgrub S; Xie XJ; Bian A; Leitch AM; Lewis CM
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1051-9. PubMed ID: 18483325
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
[TBL] [Abstract][Full Text] [Related]
59. Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue.
Bhavani V; Srinivasulu M; Ahuja YR; Hasan Q
Cancer Biomark; 2009; 5(4):207-13. PubMed ID: 19729830
[TBL] [Abstract][Full Text] [Related]
60. Methylated genes as new cancer biomarkers.
Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
